US Bancorp’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,080
| Closed | -$29.2K | – | 4212 |
|
|
2024
Q2 | $29.2K | Buy |
1,080
+73
| +7% | +$1.52K | ﹤0.01% | 2905 |
|
|
2024
Q1 | $18.4K | Hold |
1,007
| – | – | ﹤0.01% | 3132 |
|
|
2023
Q4 | $12.4K | Sell |
1,007
-1,738
| -63% | -$16.3K | ﹤0.01% | 3242 |
|
|
2023
Q3 | $41.1K | Buy |
2,745
+1,109
| +68% | +$23.1K | ﹤0.01% | 2543 |
|
|
2023
Q2 | $53.2K | Sell |
1,636
-654
| -29% | -$23.9K | ﹤0.01% | 2474 |
|
|
2023
Q1 | $89.6K | Buy |
2,290
+914
| +66% | +$44.7K | ﹤0.01% | 2245 |
|
|
2022
Q4 | $72.7K | Sell |
1,376
-33
| -2% | -$1.61K | ﹤0.01% | 2337 |
|
|
2022
Q3 | $63K | Hold |
1,409
| – | – | ﹤0.01% | 2419 |
|
|
2022
Q2 | $52K | Sell |
1,409
-264
| -16% | -$9.59K | ﹤0.01% | 2564 |
|
|
2022
Q1 | $69K | Buy |
1,673
+489
| +41% | +$17.2K | ﹤0.01% | 2457 |
|
|
2021
Q4 | $51K | Buy |
1,184
+137
| +13% | +$6.85K | ﹤0.01% | 2651 |
|
|
2021
Q3 | $58K | Buy |
1,047
+117
| +13% | +$6.12K | ﹤0.01% | 2580 |
|
|
2021
Q2 | $44K | Buy |
930
+508
| +120% | +$25.9K | ﹤0.01% | 2736 |
|
|
2021
Q1 | $22K | Buy |
422
+97
| +30% | +$5.39K | ﹤0.01% | 2988 |
|
|
2020
Q4 | $21K | Hold |
325
| – | – | ﹤0.01% | 2899 |
|
|
2020
Q3 | $22K | Buy |
325
+299
| +1,150% | +$16.3K | ﹤0.01% | 2784 |
|
|
2020
Q2 | $1K | Buy |
+26
| New | +$998 | ﹤0.01% | 3669 |
|
Other funds holding SILK
US Bancorp's SILK Position: Q3 2024 in Review
US Bancorp sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 1,080 shares — an estimated $29.2K sold.
US Bancorp first reported a position in SILK in Q2 2020 and held it in 17 quarters. The position peaked at $89.6K in Q1 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- US Bancorp reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- US Bancorp sold 1,080 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $29.2K.
- US Bancorp first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 17 quarters.
- US Bancorp's Silk Road Medical, Inc. Common Stock position peaked at $89.6K in Q1 2023.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on US Bancorp's 13F filing for Q3 2024, filed 28 Oct 2024.